semaglutide approval history of glucagon-like peptide-1 receptor agonists Novo Nordisk's Ozempic® pill, the

Food & Drug Administration (FDA) approved the GLP-1 drug Wegovy to help reduce the risk of serious heart problems among people who are overweight or have obesity who do not necessarily have type 2 diabetes

This suggests potential applications for peptides and menopause

Semaglutide is the key ingredient in market-leading injections Ozempic, prescribed on the NHS for Type 2 diabetes, and Wegovy, prescribed for weight loss

Even at higher doses like 1mg (100 units), you stay within the range of a standard syringe

A couple of things Ive noticed with GLP-1: Tirzepatide seems to be tolerated better get them on fiber supplementation and treat any underlying GERD or constipation make sure they arent overeating on their injection day I would use the minimal dose that is able to achieve weight loss with minimal to no side effects

This is an ideal formula for anyone looking to support full body repair and regeneration